170 related articles for article (PubMed ID: 19260564)
1. Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Saif I
J Pak Med Assoc; 2009 Feb; 59(2):64-7. PubMed ID: 19260564
[TBL] [Abstract][Full Text] [Related]
2. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
[TBL] [Abstract][Full Text] [Related]
3. Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
Shastri J; Tran A; Covit A; Pepe J; Sherman RA
J Ren Nutr; 2008 Jul; 18(4):370-4. PubMed ID: 18558302
[TBL] [Abstract][Full Text] [Related]
4. Frequency of maintenance hemodialysis patients meeting K/DOQI criteria for serum calcium, phosphorus, calcium phosphorus product and PTH levels; a single institutional experience from Pakistan: a cross sectional study.
Janjua TK; Mukhtar KN; Naveed AK; Ahmed EB; Rehan M
Pan Afr Med J; 2019; 33():183. PubMed ID: 31565143
[TBL] [Abstract][Full Text] [Related]
5. Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis.
Arenas MD; Alvarez-Ude F; Torregrosa V; Gil MT; Carretón MA; Moledous A; Nuñez C; Devesa R; Albiach B
J Nephrol; 2007; 20(4):453-61. PubMed ID: 17879212
[TBL] [Abstract][Full Text] [Related]
6. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
[TBL] [Abstract][Full Text] [Related]
7. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
Arenas MD; Alvarez-Ude F; Gil MT; Moledous A; Malek T; Nuñez C; Devesa R; Carretón MA; Soriano A
Nephrol Dial Transplant; 2007 Jun; 22(6):1639-44. PubMed ID: 17277339
[TBL] [Abstract][Full Text] [Related]
8. K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?
Wei M; Taskapan H; Esbaei K; Jassal SV; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2006; 38(3-4):739-43. PubMed ID: 17160632
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study.
Górriz JL; Molina P; Bover J; Barril G; Martín-de Francisco AL; Caravaca F; Hervás J; Piñera C; Escudero V; Molinero LM;
Nefrologia; 2013 Jan; 33(1):46-60. PubMed ID: 23364626
[TBL] [Abstract][Full Text] [Related]
11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
[TBL] [Abstract][Full Text] [Related]
13. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
Wazny LD; Raymond CB; Lesperance EM; Bernstein KN
CANNT J; 2008; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
[TBL] [Abstract][Full Text] [Related]
14. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
Panawong W; Chaiyakum A; Pongskul C
J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
[TBL] [Abstract][Full Text] [Related]
15. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran.
Mahdavi-Mazdeh M; Zamyadi M; Norouzi S; Heidary Rouchi A
Iran J Kidney Dis; 2007 Jul; 1(1):25-8. PubMed ID: 19357440
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.
Tsai WC; Peng YS; Yang JY; Hsu SP; Wu HY; Pai MF; Chang JF; Chen HY
Blood Purif; 2013; 36(2):116-21. PubMed ID: 24217122
[TBL] [Abstract][Full Text] [Related]
17. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
[TBL] [Abstract][Full Text] [Related]
18. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
19. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.
Noordzij M; Korevaar JC; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT;
Am J Kidney Dis; 2005 Nov; 46(5):925-32. PubMed ID: 16253734
[TBL] [Abstract][Full Text] [Related]
20. [CA-P control in haemodialysis and K/DOQI guidelines].
Rivera F; Sánchez de la Nieta MD; Echarri R; Anaya S; Carreño A; Vozmediano MC; Alcaide MP
Nefrologia; 2006; 26(3):351-7. PubMed ID: 16892824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
